Magazine

Magazine

April 2017, Volume 3, Issue 5

This issue examines the art and science of myeloma drug sequencing, Mikkael Sekeres' letter to the ABIM, highlights from the 16th International Myeloma Workshop, and more.

March 2017, Volume 3, Issue 4

This issue takes a look at diversity in the medical education system, provides a hematology drug pipeline update, and more.

February 2017, Volume 3, Issue 3

This issue features highlights from the 2016 ASH Annual Meeting, a look at the dangers of predatory publishing, and more.

January 2017 Annual Meeting Edition

This issue features expanded coverage of the 2016 ASH Annual Meeting, as well as a focus on CAR T-cell therapy, and more.

January 2017, Volume 3, Issue 1

This issue features highlights from the 2016 ASH Annual Meeting, a look at the dangers of predatory publishing, and more.

December 2016, Volume 2, Issue 12

This issue features a look at the 2016 ASH Mentor Awards, a preview of the ASH Annual Meeting, the challenges of designing a clinical trial that is both internally and externally valid, and more.

November 2016, Volume 2, Issue 11

This issue examines challenges related to obtaining insurance coverage for bone marrow transplants in older adults, discusses how to prepare for an educational or scientific presentation, and more.

Focus on Rare Diseases (October 2016, Volume 2, Issue 10.1)

This supplement features FDA updates, clinical trials, policy updates, and the latest research in hematologic rare diseases.

October 2016, Volume 2, Issue 10

This issue looks at the pros and cons of open-access publishing, features updates from the ASH Meeting on Hematologic Malignancies, and shares tips for incorporating small-group instruction.

Focus on Trainees & Fellows (September 2016, Volume 2, Issue 9.1)

This special edition features advice and resources for trainees and fellows.
Advertisement

Current Issue

November 2017, Volume 3, Issue 13

This issue features a behind-the-scenes look at the ASH annual meeting, bringing newly approved gene therapies to patients, and more.